NIH JOINED BY ADVOCACY GROUPS TO FUND RESEARCH ON AUTISM SUSCEPTI BILITY GENES

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
National Institute of Mental Health (NIMH)  
http://www.nimh.nih.gov/

FOR IMMEDIATE RELEASE: Tuesday, October 18, 2005 

CONTACT: Jennifer Loukissas, NIMH Press Office, 301-443-4536,
nimhpress@xxxxxxx

NIH JOINED BY ADVOCACY GROUPS TO FUND RESEARCH ON AUTISM SUSCEPTIBILITY
GENES
 
Five institutes at the National Institutes of Health (NIH) and three private
autism organizations have formed a consortium to pursue their common goal of
understanding a devastating disorder. This public-private partnership has
funded five grants representing three projects to identify genes that may
contribute to the development of autism and Autism Spectrum Disorders. The
National Institute of Mental Health will administer the $10.8 million awards
over the next five years. 

The participating NIH institutes are The National Institute of Child Health
and Human Development (NICHD), The National Institute on Deafness and Other
Communication Disorders (NIDCD), The National Institute of Environmental
Health Sciences (NIEHS), The National Institute of Mental Health (NIMH), and
The National Institute of Neurological Disorders and Stroke (NINDS). The
voluntary organizations contributing funds are Cure Autism Now (CAN),
National Alliance for Autism Research (NAAR), and the Southwest Autism
Research & Resource Center (SARRC). 

Autism is a neurodevelopmental disorder that causes severe and pervasive
impairment in thinking, feeling, language, and the ability to relate to
others. In an average year, one to six new cases of autism arise per 1,000
children. Experts believe that as high as 90 percent of the variance in the
disorder is due to hereditary factors, and research suggests a strong
interaction between environmental factors and multiple unknown genes. As
researchers gain a better understanding of the genes responsible for autism,
they may be better able to distinguish between the different variants of the
disorder and to develop targeted therapies and interventions to treat them. 

"This initiative seeks to expand our knowledge of the genetic factors
involved in this disorder that affects so many families, said NIMH Director
Thomas R. Insel, M.D. "New technologies in gene research can allow
scientists to better understand the role genes play in the development of
autism, and eventually lead to better treatments." 

Five grants have been awarded to three teams of investigators: 

-- A three-site collaborative project, involving Rutgers University, the
University of Medicine and Dentistry of New Jersey, the Robert Wood Johnson
Medical School, and University of Iowa, for a project entitled
"Identification and Functional Assessment of Autism Susceptibility Genes"
with investigators Linda Brzustowicz, M.D., James Millonig, Ph.D., and
Veronica Vieland, Ph.D., respectively. 

-- Cold Spring Harbor Laboratory for a project entitled, "Determining the
Genetic Basis of Autism by High-Resolution Analysis of Copy Number,"
directed by Jonathan Sebat, Ph.D. 

-- Emory University, for a project entitled, "Identifying Autism
Susceptibility Genes by High-Throughput Chip Resequencing," directed by
Michael Zwick, Ph.D. 
The three-site collaborative project uses novel statistical methods, fine
mapping of candidate regions across the genome, and animal models in the
search for autism susceptibility genes. 

Cold Spring Harbor Laboratory's proposal also is highly innovative,
capitalizing on the recent discovery of the existence and extent of the high
variability of the human genome. Dr. Sebat will examine gene sequence data
in order to identify genes and other genomic elements that have either been
deleted (micro deletions) or repeated (some many times over). These
extensive gene alterations may contribute to the range of Autism Spectrum
Disorders. 

The Emory project seeks to explore forms of familial inheritance through the
X chromosome -- because more males than females are diagnosed with autism.
Zwick will use a highly innovative technology with great promise for DNA
sequencing. It is hoped that this study might lead to insights into autism
and a related disorder, Fragile X syndrome. 

These new initiatives complement a large autism genetics project funded by
NIMH earlier this year and awarded to Johns Hopkins University for research
led by Aravinda Chakravarti, Ph.D. This effort employs state-of-the-art gene
chips to study variation across the genome in children with autism. This
study has already yielded interesting results that point to candidate
genomic regions on chromosomes 7, 10, and 19. These signals will provide
important clues to the three new genetics projects funded by the
consortium.* 

These studies would not be possible without the support of the NIMH Human
Genetics Initiative** and its large data and sample repository which is
available to investigators who study the genetics of autism. It is the
largest such facility for mental disorders in the world and collects data
and blood samples, makes cell lines, stores DNA and clinical data for autism
and other mental disorders. 

For more information on Autism Spectrum Disorders, visit
http://www.nimh.nih.gov/healthinformation/autismmenu.cfm. 

*For information about similar projects in genetic research on autism, visit
http://www.nimh.nih.gov/press/autismgenetics.cfm. 

**For more information about the NIMH Human Genetics Initiative, visit
www.nimhgenetics.org. 

NIMH is one of the 27 components that make up NIH, the Federal Government's
primary agency for biomedical and behavioral research. NIH is part of the
Department of Health and Human Services. 

The National Institutes of Health (NIH) -- "The Nation's Medical Research
Agency" -- includes 27 Institutes and Centers and is a component of the U.
S. Department of Health and Human Services. It is the primary Federal agency
for conducting and supporting basic, clinical, and translational medical
research, and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and its programs,
visit http://www.nih.gov.
  
##
 
This NIH News Release is available online at:
http://www.nih.gov/news/pr/oct2005/nimh-18.htm.

To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux